Home › Asset managers › Compare 2025-2026 › JPMorgan vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
JPMorgan 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 30,437 | 24,523 | 1,668 | 4,246 | 93.6% | 88.3% |
| Board proposals | 24,375 | 19,281 | 1,523 | 3,571 | 92.7% | 87.6% |
| E&S shareholder proposals | 144 | 7 | 0 | 137 | 100.0% | 43.7% |
| Other items | 5,918 | 5,235 | 145 | 538 | 97.3% | 92.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
4,246 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | JPMorgan | Brighthouse |
|---|---|---|---|---|---|---|
| AUTONATION, INC. | April 28, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| AUTONATION, INC. | April 28, 2026 | Ratification of the selection of KPMG LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| AVALONBAY COMMUNITIES, INC. | May 20, 2026 | Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their respective successors are elected and qualify: Glyn F. Aeppel Director Elections |
Board | For | FOR 15 funds |
Split 1 FOR, 2 ABSTAIN |
| AVALONBAY COMMUNITIES, INC. | May 20, 2026 | To adopt a resolution approving, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and any related material disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 17 funds |
Split 6 FOR, 2 ABSTAIN |
| AVALONBAY COMMUNITIES, INC. | May 20, 2026 | To ratify the selection of Ernst & Young LLP as the Company's independent auditors for the year ending December 31, 2026. Audit-related |
Board | For | FOR 15 funds |
Split 6 FOR, 2 ABSTAIN |
| AVANTOR, INC. | May 7, 2026 | Advisory Approval of Named Executive Officer Compensation Say-on-Pay |
Board | For | FOR 3 funds |
Split 4 FOR, 2 ABSTAIN |
| AVANTOR, INC. | May 7, 2026 | Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026 Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 2 ABSTAIN |
| AVEANNA HEALTHCARE HOLDINGS INC. | May 29, 2026 | To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
Split 1 AGAINST, 1 ABSTAIN |
| AVEANNA HEALTHCARE HOLDINGS INC. | May 29, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending January 2, 2027. Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| AVERY DENNISON CORPORATION | April 30, 2026 | Approval, on an advisory basis, of our executive compensation. Say-on-Pay |
Board | For | FOR 9 funds |
Split 6 FOR, 2 ABSTAIN |
| AVERY DENNISON CORPORATION | April 30, 2026 | Ratification of the appointment of PwC as our independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 6 funds |
Split 6 FOR, 2 ABSTAIN |
| AVIENT CORPORATION | May 14, 2026 | Approval, on an advisory basis, of Named Executive Officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
Split 6 FOR, 2 ABSTAIN |
| AVIENT CORPORATION | May 14, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 6 FOR, 2 ABSTAIN |
| AVIS BUDGET GROUP, INC. | May 20, 2026 | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| AVIS BUDGET GROUP, INC. | May 20, 2026 | To vote, on an advisory basis, on the approval of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
Split 3 FOR, 1 ABSTAIN |
| AVISTA CORP. | May 14, 2026 | Advisory (non-binding) vote on executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
Split 5 FOR, 2 ABSTAIN |
| AVISTA CORP. | May 14, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 4 funds |
Split 5 FOR, 2 ABSTAIN |
| AVOLTA AG | May 6, 2026 | Approve Remuneration Report (Non-Binding) Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 1 AGAINST |
| AXALTA COATING SYSTEMS LTD | June 3, 2026 | Non-binding advisory vote to approve the compensation of our named executive officers Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 1 ABSTAIN |
| AXALTA COATING SYSTEMS LTD. | June 3, 2026 | Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm and auditor until the conclusion of the 2027 Annual General Meeting of Members and delegation of authority to the Board, acting through the Audit Committee, to set the terms and remuneration thereof Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| AXCELIS TECHNOLOGIES, INC. | May 5, 2026 | Proposal to ratify independent public accounting firm. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| AXCELIS TECHNOLOGIES, INC. | May 5, 2026 | Say on Pay - An advisory vote on the approval of executive compensation. Say-on-Pay |
Board | For | FOR 4 funds |
Split 4 FOR, 1 ABSTAIN |
| AXIS CAPITAL HOLDINGS LIMITED | May 14, 2026 | To appoint Deloitte Ltd., Hamilton, Bermuda, to act as our independent registered public accounting firm for the fiscal year ending December 31, 2026 and to authorize the Board of Directors, acting through the Audit Committee, to set the fees for the independent registered public accounting firm; Audit-related |
Board | For | FOR 5 funds |
Split 4 FOR, 2 ABSTAIN |
| AXIS CAPITAL HOLDINGS LIMITED | May 14, 2026 | To approve, by non-binding vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 1 FOR, 2 ABSTAIN |
| AXON ENTERPRISE, INC. | May 28, 2026 | Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 7 FOR, 1 AGAINST, 3 ABSTAIN |
| AXON ENTERPRISE, INC. | May 28, 2026 | Proposal No. 3 requests that shareholders vote to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 6 funds |
Split 8 FOR, 3 ABSTAIN |
| AXOS FINANCIAL, INC. | November 13, 2025 | Election of Director: James J. Court Director Elections |
Board | For | Split 4 FOR, 1 WITHHOLD |
FOR 1 fund |
| AXSOME THERAPEUTICS, INC. | June 5, 2026 | To approve, by non-binding advisory vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 5 FOR, 1 ABSTAIN |
| AXSOME THERAPEUTICS, INC. | June 5, 2026 | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 5 FOR, 1 ABSTAIN |
| Alibaba Group Holding Limited | September 25, 2025 | Approve PricewaterhouseCoopers Zhong Tian LLP and PricewaterhouseCoopers as U.S. and Hong Kong Auditors, Respectively, and Authorize Board to Fix Their Remuneration Audit-related |
Board | For | FOR 16 funds |
Split 3 FOR, 3 AGAINST |
| Apollo Hospitals Enterprise Ltd. | August 29, 2025 | Approve Issuance of Non-Convertible Debentures on Private Placement Basis Capital Structure |
Board | For | FOR 5 funds |
Split 1 FOR, 1 AGAINST |
| Asahi Group Holdings Ltd. | March 24, 2026 | Approve Allocation of Income, with a Final Dividend of JPY 26 Capital Structure |
Board | For | FOR 6 funds |
Split 1 FOR, 2 AGAINST |
| BADGER METER, INC. | April 24, 2026 | ADVISORY VOTE TO APPROVE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| BADGER METER, INC. | April 24, 2026 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR 2026. Audit-related |
Board | For | FOR 7 funds |
Split 5 FOR, 2 ABSTAIN |
| BAKER HUGHES COMPANY | May 19, 2026 | An advisory vote related to the Company's executive compensation program Say-on-Pay |
Board | For | FOR 31 funds |
Split 7 FOR, 1 AGAINST, 3 ABSTAIN |
| BAKER HUGHES COMPANY | May 19, 2026 | The approval of the Second Amended and Restated Baker Hughes Company Employee Stock Purchase Plan Compensation |
Board | For | FOR 27 funds |
Split 8 FOR, 3 AGAINST |
| BAKER HUGHES COMPANY | May 19, 2026 | The ratification of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2026 Audit-related |
Board | For | FOR 27 funds |
Split 8 FOR, 3 ABSTAIN |
| BALCHEM CORPORATION | June 18, 2026 | Advisory approval of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 1 ABSTAIN |
| BALCHEM CORPORATION | June 18, 2026 | Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year 2026. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| BALL CORP | April 29, 2026 | Approve, by non-binding vote, the compensation paid to the named executive officers. Say-on-Pay |
Board | For | FOR 12 funds |
Split 4 FOR, 2 ABSTAIN |
| BALL CORPORATION | April 29, 2026 | Approve, an amendment to the Amended and Restated 2013 Stock and Cash Incentive Plan. Compensation |
Board | For | FOR 9 funds |
Split 4 FOR, 2 ABSTAIN |
| BALL CORPORATION | April 29, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the company for 2026. Audit-related |
Board | For | FOR 9 funds |
Split 4 FOR, 2 ABSTAIN |
| BANC OF CALIFORNIA, INC. | May 6, 2026 | Approval of the Company's Second Amended and Restated 2018 Omnibus Stock Incentive Plan. Compensation |
Board | For | Split 1 FOR, 3 AGAINST |
Split 2 FOR, 1 AGAINST, 1 ABSTAIN |
| BANC OF CALIFORNIA, INC. | May 6, 2026 | Approval, on an advisory and non-binding basis, of the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| BANC OF CALIFORNIA, INC. | May 6, 2026 | Ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| BANCA MONTE DEI PASCHI DI SIENA SPA | April 15, 2026 | Slate 1 Submitted by Board of Directors Director Elections |
Board | For | AGAINST 3 funds |
Split 1 FOR, 1 AGAINST |
| BANCFIRST CORPORATION | May 28, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| BANCFIRST CORPORATION | May 28, 2026 | To ratify the selection of Forvis Mazars, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| BANCO BPM S.P.A. | April 16, 2026 | Slate 1 Submitted by Board of Directors Director Elections |
Board | For | FOR 7 funds |
Split 1 FOR, 1 AGAINST |
| BANK OF AMERICA CORPORATION | May 4, 2026 | Election of Director: Arnold W. Donald Director Elections |
Board | For | Split 28 FOR, 1 ABSTAIN |
FOR 2 funds |
| BANK OF AMERICA CORPORATION | May 4, 2026 | Election of Director: Maria T. Zuber Director Elections |
Board | For | Split 28 FOR, 1 ABSTAIN |
FOR 2 funds |
| BANK OF AMERICA CORPORATION | May 4, 2026 | Election of Director: Michael D. White Director Elections |
Board | For | Split 28 FOR, 1 ABSTAIN |
FOR 2 funds |
| BANK OF AMERICA CORPORATION | May 4, 2026 | Election of Director: Monica C. Lozano Director Elections |
Board | For | Split 28 FOR, 1 ABSTAIN |
FOR 2 funds |
| BANK OF AMERICA CORPORATION | May 4, 2026 | Election of Director: Sharon L. Allen Director Elections |
Board | For | Split 28 FOR, 1 ABSTAIN |
FOR 2 funds |
| BANK OF AMERICA CORPORATION | May 4, 2026 | Election of Director: Thomas D. Woods Director Elections |
Board | For | Split 28 FOR, 1 ABSTAIN |
FOR 2 funds |
| BANK OF AMERICA CORPORATION | May 4, 2026 | Ratifying the appointment of our independent registered public accounting firm for 2026 Audit-related |
Board | For | Split 28 FOR, 1 AGAINST |
Split 8 FOR, 1 AGAINST, 5 ABSTAIN |
| BANK OF HAWAII CORPORATION | April 24, 2026 | Ratification of the Re-appointment of Ernst & Young LLP for 2026. Audit-related |
Board | For | AGAINST 1 fund |
Split 3 FOR, 2 ABSTAIN |
| BANK OF HAWAII CORPORATION | April 24, 2026 | Say on Pay - An advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 1 fund |
Split 3 AGAINST, 2 ABSTAIN |
| BANK OZK | May 18, 2026 | To approve the Amended and Restated 2019 Omnibus Equity Incentive Plan. Compensation |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| BANK OZK | May 18, 2026 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| BANK OZK | May 18, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| BANKUNITED, INC. | May 21, 2026 | Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| BANKUNITED, INC. | May 21, 2026 | To approve the BankUnited, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan. Compensation |
Board | For | Split 1 FOR, 6 AGAINST |
Split 3 AGAINST, 1 ABSTAIN |
| BANKUNITED, INC. | May 21, 2026 | To ratify the Audit Committee's appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026; Audit-related |
Board | For | FOR 7 funds |
Split 3 FOR, 1 ABSTAIN |
| BATH & BODY WORKS, INC. | June 11, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
Split 2 FOR, 2 ABSTAIN |
| BATH & BODY WORKS, INC. | June 11, 2026 | Ratification of the appointment of our independent registered public accounting firm. Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 2 ABSTAIN |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Advisory Vote to Approve Named Executive Officer Compensation for 2025 Say-on-Pay |
Board | For | FOR 7 funds |
Split 4 FOR, 2 ABSTAIN |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan Compensation |
Board | For | AGAINST 4 funds |
Split 4 AGAINST, 2 ABSTAIN |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Ratification of Appointment of Independent Registered Public Accounting Firm for 2026 Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| BEACON FINANCIAL CORPORATION | May 13, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 1 FOR, 2 AGAINST, 1 ABSTAIN |
| BEACON FINANCIAL CORPORATION | May 13, 2026 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | Split 3 FOR, 1 AGAINST |
Split 3 FOR, 1 ABSTAIN |
| BEAM THERAPEUTICS INC. | June 3, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| BEAM THERAPEUTICS INC. | June 3, 2026 | Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 2 ABSTAIN |
| BECTON DICKINSON & CO. | January 27, 2026 | Advisory Vote to Ratify Named Executive Officers' Compensation Say-on-Pay |
Board | For | AGAINST 12 funds |
Split 1 FOR, 1 AGAINST, 1 ABSTAIN |
| BELDEN INC. | May 21, 2026 | Advisory vote on executive compensation for 2025. Say-on-Pay |
Board | For | FOR 4 funds |
Split 6 FOR, 1 ABSTAIN |
| BELDEN INC. | May 21, 2026 | Amendment and Restatement of the Belden 2021 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
Split 6 FOR, 1 ABSTAIN |
| BELDEN INC. | May 21, 2026 | Ratification of the appointment of Ernst & Young as the Company's Independent Registered Public Accounting Firm for 2026. Audit-related |
Board | For | FOR 3 funds |
Split 6 FOR, 1 ABSTAIN |
| BENCHMARK ELECTRONICS, INC. | May 28, 2026 | To approve an amendment to the Benchmark Electronics, Inc. 2019 Omnibus Incentive Compensation Plan to increase the total number of authorized shares of the Company's common stock available for grant hereunder by 1,800,000 shares; and Compensation |
Board | For | AGAINST 4 funds |
Split 2 FOR, 1 AGAINST, 1 ABSTAIN |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | To approve, on an advisory (non-binding) basis, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 2 ABSTAIN |
| BENTLEY SYSTEMS, INCORPORATED | May 21, 2026 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| BERKSHIRE HATHAWAY INC. | May 2, 2026 | Non-binding resolution to approve the compensation of the Company's Named Executive Officers, as described in the 2026 Proxy Statement. Say-on-Pay |
Board | For | FOR 29 funds |
Split 2 FOR, 7 AGAINST, 6 ABSTAIN |
| BEST BUY CO., INC. | June 12, 2026 | To approve in a non-binding advisory vote our named executive officer compensation Say-on-Pay |
Board | For | FOR 20 funds |
Split 4 FOR, 2 ABSTAIN |
| BEST BUY CO., INC. | June 12, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending January 30, 2027 Audit-related |
Board | For | FOR 16 funds |
Split 4 FOR, 2 ABSTAIN |
| BETA BIONICS, INC. | May 21, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| BILLIONTOONE, INC. | June 10, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as BillionToOne, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 1 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. Compensation |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | FOR 2 funds |
Split 3 AGAINST, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To hold a non-binding, advisory vote regarding executive compensation. Say-on-Pay |
Board | For | FOR 3 funds |
Split 3 AGAINST, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. Audit-related |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | Say on Pay - To hold an advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 12 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 10 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | A non-binding advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. Compensation |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMERIEUX SA | May 28, 2026 | APPROVE COMPENSATION OF ALEXANDRE MERIEUX, CHAIRMAN OF THE BOARD Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 AGAINST |
← Previous Page 11 of 43 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.